C&EN

In Silico Identification and Verification of the Anticancer Mechanism of TMBM-010 from Oxytropis herba with a Rational Delivery System Design

Tianjin Key Laboratory of Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmaceutical Sciences, Tianjin Medical University, Tianjin 300070, China ...
IEEE

Molecular Mechanism of Rhizoma Coptidis in Treating Polycystic Ovary Syndrome Combined with Type 2 Diabetes Mellitus: A Network Pharmacology Study

Abstract: OBJECTIVE:To explore the molecular mechanisms of Rhizoma Coptidis in the treatment of polycystic ovary syndrome (PCOS) combined with type 2 diabetes mellitus (T2DM) using network ...
Frontiers

Editorial: Community series in unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies, volume II

A total of 25 papers are included in this series. We selected seven as representative: Yang et al. discussed the role of lipid metabolism in gastric cancer. Their study identified 78 genes related to ...
IEEE

Transcriptome Sequencing to Explore the Mechanism of Qiwei Baizhu San in Treating T2DM

Abstract: Objective: This study aims to explore the mechanism of Qiwei Baizhu San in treating T2DM by high-throughput transcriptome sequencing. Methods: T2DM rats were made by STZ + high fat and high ...
Frontiers

Pan-Cancer Analyses Reveal Oncogenic and Immunological Role of PLOD2

General Surgery of Beijing Jishuitan Hospital, The Fourth Clinical Medical College of Peking University, Beijing, China The differences of PLOD2 gene expression were compared according to TNM stages ...
BioSpace

LifeMap Sciences, A Subsidiary Of BioTime, Announces The Launch Of TGex, The Knowledge-Driven NGS Analysis Platform, Powered By The Genecards Suite

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. (“LifeMap”), a life sciences technology company and subsidiary of BioTime, Inc., announced today the market launch of TGex™ (Translational ...